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Abstract: Consumption of a Western type diet is a known risk factor for colorectal cancer. Our group
previously developed the total Western diet (TWD) for rodents with energy and nutrient profiles
that emulate a typical Western diet. In this study, we tested the hypothesis that consumption of
the TWD would enhance colitis, delay recovery from gut injury and promote colon tumorigenesis.
In multiple experiments using the azoxymethane + dextran sodium sulfate or ApcMin/+ mouse models
of colitis-associated colorectal carcinogenesis (CAC), we determined that mice fed TWD experienced
more severe and more prolonged colitis compared to their counterparts fed the standard AIN93G diet,
ultimately leading to markedly enhanced colon tumorigenesis. Additionally, this increased tumor
response was attributed to the micronutrient fraction of the TWD, and restoration of calcium and
vitamin D to standard amounts ameliorated the tumor-promoting effects of TWD. Finally, exposure to
the TWD elicited large scale, dynamic changes in mRNA signatures of colon mucosa associated with
interferon (IFN) response, inflammation, innate immunity, adaptive immunity, and antigen processing
pathways, among others. Taken together, these observations indicate that consumption of the TWD
markedly enhanced colitis, delayed recovery from gut injury, and enhanced colon tumorigenesis
likely via extensive changes in expression of immune-related genes in the colon mucosa.
Keywords: Western diet; colitis; inflammation; colorectal cancer; calcium; vitamin D;
transcript profiling
1. Introduction
Colorectal cancer (CRC) is the third leading cause of cancer death and the third most commonly
diagnosed cancer in men and women in the United States [1]. Epidemiological data suggest that risk
of CRC is strongly linked to long-term inflammatory bowel diseases (IBD), of which the most common
types are Crohn’s disease and ulcerative colitis (UC) [2–4]. The chronic intestinal inflammation that
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characterizes these conditions is now recognized as an important factor in CRC due to its involvement
in the disruption of the same oncogenic pathways that are disrupted in CRC [5]. The mutation of genes
involved in the maintenance of the intestinal mucosal barrier that protects the intestinal wall from
bacterial invasion contributes to both Crohn’s and UC [6,7].
Dysfunction of the intestinal mucosal barrier leads to sustained damage of gut epithelial cells.
This chronic injury to the gut triggers a compensatory immune response characterized by the
up-regulation of cell proliferation and anti-apoptotic pathways that promote cell survival [8]. Various
molecules are involved in the activation of such pathways, including transcription factors (e.g., NF-κB,
and STAT3) and various inflammatory cytokines (e.g., IL-6 and TNF- α), which are normally secreted
during an inflammatory response. The resulting compensatory cell regeneration results in increased
rates of mitosis that, when chronically active, increase DNA mutation rates [8,9]. Not only can
this process promote the disruption of oncogenic pathways, but it can also provide cancerous cells
with a nurturing environment due to the increased availability of proliferative and survival signals.
This notion is supported by an animal study by Tanaka et al. [10], in which a combined treatment of
the chemical carcinogen azoxymethane (AOM) with the inflammatory agent dextran sodium sulfate
(DSS) significantly increased intestinal tumorigenesis in CD-1 mice. The AOM + DSS model yields
a consistent, reproducible colon cancer outcome that is well defined in terms of mouse strain and
AOM dosage [11]. Moreover, this model recapitulates many of the molecular events that occur in
spontaneous human colon cancer, such as β-catenin accumulation and K-ras mutations [12].
In recent decades, global incidence rates of colorectal cancer have been increasing, reportedly
due to an increased prevalence of certain lifestyle trends, including decreased physical activity and
consumption of “Westernized” diets [13]. The typical Western diet is characterized by increased intake
of highly processed foods that contain excess levels of fat, sodium, and refined sugars and are generally
low in some of the essential vitamins and minerals, as well as fiber [14–16]. Diet is one of the most
influential factors affecting overall cancer incidence, with CRC being one of the most well-established
examples. Evidence from epidemiological and pre-clinical animal studies supports the contention that
the Western diet is positively associated with higher risk and incidence of CRC [14,16]. Yet, in the vast
majority of pre-clinical animal studies designed to investigate molecular mechanisms of carcinogenesis
or cancer prevention or to identify new strategies for dietary cancer prevention, researchers routinely
employ standard basal diets that are generally balanced with respect to macro- and micronutrient levels
to sustain animal health, such as the American Institute of Nutrition AIN93G/M diet formulations [17].
However, these standardized rodent diets are not relevant to most human nutrition patterns, especially
for at-risk populations that frequently consume energy-dense, nutrient-poor foods. Other approaches
to model Western nutrition in preclinical animal studies suffer from inconsistent reproducibility (e.g.,
the “cafeteria” diet) or insufficient consideration of diverse sources of dietary fat (e.g., the standardized
diet-induced obesity diet).
In a series of studies over the past twenty years, Newmark and colleagues have employed a
selective approach in modeling the Western diet, wherein specific components of the diet were modified
to emulate typical U.S. intakes [18–20]. In their first study, Newmark et al. developed a “stress” diet,
which was quite low in calcium and vitamin D3, and modestly reduced in phosphate compared to the
reference diet AIN76; also, the stress diet contained 20% fat as corn oil (40% of calories) compared
to only 5% (12% of calories) in the reference diet [18]. Rats and mice fed this stress diet for 12 weeks
developed hyperplasia and hyperproliferation in the colon. Subsequent studies extended this stress
diet to incorporate dietary components necessary for generation of methyl donor molecules (folic
acid, methionine, choline, and vitamin B12) and determined that this new Western diet enhanced
spontaneous tumor development in aged C57BL/6J mice, an effect that was reversed when calcium and
vitamin D were added back to the stress diet [19,20]. Although this series of studies has demonstrated
a role for dietary calcium and vitamin D3 in modulating spontaneous colon carcinogenesis in mice,
the scope of the diet remained limited in that it did not consider possible contributions of the dietary
fat source, carbohydrates or proteins and did not reflect typical Westernized nutrition patterns for
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other key micronutrients, such as sodium, selenium, or vitamins A or E. Commercial Western diets
have also been developed for the study of obesity; these diets (referred to as diet-induced obesity, or
DIO, diets) typically contain 45% or 60% of energy as fat and differ from the AIN93G diets primarily in
their high lard and sucrose content [21]. Although these high fat diets effectively induce obesity in
rodents [22], they are extreme in their sugar and fat compositions when compared to a typical Western
dietary pattern and do not differ substantially from AIN93G diets in micronutrient content [21].
Importantly, none of the approaches described above for modeling typical Western nutrition
appropriately considered the contribution of suboptimal micronutrient intakes in their disease models.
To address this research gap, our research team developed the new total Western diet (TWD) for rodents
with energy and nutrient profiles that emulate a typical Western diet using available U.S. nutrient
intake survey data [23]. Briefly, the amount of each macro- and micronutrient in the AIN93G basal
diet, a diet routinely used in cancer studies today, was adjusted to match 50th percentile intakes for
Americans as reported in NHANES survey data. These mass amounts were then adjusted for caloric
intake. Overall, the TWD is not necessarily extreme in the level of any given nutrient, but rather reflects
the overall dietary pattern of the U.S. The TWD has fewer calories from protein and carbohydrate
sources, and twice that from fat as compared to the AIN93G diet. The TWD contains more saturated
and monounsaturated fats, less polyunsaturated fat, more complex carbohydrates, and twice the level
of simple sugars. The TWD has less calcium, copper, folate, thiamine, and vitamins B6, B12, D, and E,
but much more sodium. This newly devised diet that better represents typical U.S. nutrition is highly
useful for studies employing animal models of human cancer. For example, results of a preliminary
experiment in A/J mice initiated with AOM indicated that the TWD markedly enhanced development
of preneoplastic ACF compared to the reference diet AIN93G [24]. Yet, the impact of a Western type
diet on colon inflammation and subsequent colon tumorigenesis is not known. Given the importance
of chronic colitis as a risk factor for development of inflammation-associated colorectal cancer (CAC),
the overarching objective of this work was to test the hypothesis that consumption of the TWD would
enhance colitis, delay recovery from gut injury, and promote colon tumorigenesis.
2. Materials and Methods
2.1. Chemicals and Reagents
Azoxymethane (AOM) was purchased from Sigma-Aldrich (St. Louis, MO; CAS No. 25843-45-2).
Due to variable availability, reagent grade dextran sodium sulfate (DSS) was purchased from multiple
sources, as indicated: Experiment A, mol. wt. 36-50 kDa, MP Biomedicals (via ThermoFisher
Scientific, Waltham, MA); Experiment B-E, mol. wt. ~40 kDa, Alfa Aezar (via either VWR, Radnor,
PA or ThermoFisher). All other chemicals used were of reagent grade and purchased from general
laboratory suppliers.
2.2. Animals and Experimental Diets
The Utah State University Institutional Animal Care and Use Committee approved all procedures
for the handling and treatment of mice used in this study (protocols 2114, 2262, 2404). Animals
were housed in the Laboratory Animal Research Center (LARC) at Utah State University, which is
an AAALAC approved facility. Mice were maintained in a specific pathogen-free vivarium at 18 to
23 ◦C with humidity at 50% and with a 12:12 h dark:light cycle. Mice were provided Bed-o’Cobs®
1/4 bedding (Andersons, Cincinnati, OH) and housed in HEPA-filtered cages on a IVC Air Handling
Solutions ventilated housing system (Tecniplast, Buguggiate, Italy). C57BL/6J mice were obtained from
Jackson Laboratories (Bar Harbor, ME) at 3 or 4 weeks of age and acclimated to the vivarium for 1
week. All experimental diets were formulated by Envigo (Hackensack, NJ; formerly Harlan-Teklad)
as outlined in Table 1. Diets were obtained as a single lot from the vendor and maintained at 4 ◦C
for the duration of the study. For all experiments, fresh food was provided twice per week, and food
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consumption was monitored at each change (including accounting for spillage into the cage). Fresh
water was provided weekly. Individual body weights were recorded once per week for all mice.
Table 1. Composition of experimental diets.
AIN93G





Energy density (kcal/g) 3.8 4.4 4.6 3.7 4.4 4.4 4.4
Macronutrients
Carbohydrates (g/kg diet)
Corn starch 398 230 85 398 230 230 230
Maltodextrin 132 70 115 132 70 70 70
Sucrose 100 261 200 100 261 261 261
Cellulose 50 30 58 50 30 30 30
kcal (% of total) 60.1% 54.5% 36.2% 60.1% 54.5% 54.5% 54.5%
Proteins (g/kg)
Casein 200 190 245 200 190 190 190
L-cystine 3 2.8 3.5 3 2.8 2.8 2.8
kcal (% of total) 18.8% 15.4% 19.0% 18.8% 15.4% 15.4% 15.4%
Fats (g/kg)
Soybean oil 70 31.4 30 70 31.4 31.4 31.4
Anhydrous milk fat 0 36.3 0 0 36.3 36.3 36.3
Olive oil 0 28.0 0 0 28.0 28.0 28.0
Lard 0 28.0 195 0 28.0 28.0 28.0
Beef tallow 0 24.8 0 0 24.8 24.8 24.8
Corn oil 0 16.5 0 0 16.5 16.5 16.5
Cholesterol 0 0.4 0 0 0.4 0.4 0.4
kcal (% of total) 17.2% 34.5% 44.8% 17.2% 34.5% 34.5% 34.5%
Micronutrients
Minerals (mg/kg)
Calcium 5000 2011 5000 2011 5000 5000 2011
Phosphorus 3000 2757 3000 2757 3000 2757 2757
Sodium 1019 7078 1019 7078 1019 7078 7078
Potassium 3600 5333 3600 5333 3600 5333 5333
Magnesium 507 589 507 589 507 589 589
Iron 35 31 35 31 35 31 31
Zinc 30 25 30 25 30 25 25
Copper 6 2.6 6 2.6 6 2.6 2.6
Selenium 0.15 0.2 0.15 0.2 0.15 0.2 0.2
Vitamins (unit/kg)
Thiamin (mg) 5 3.5 5 3.5 5 3.5 3.5
Riboflavin (B2) (mg) 6 4.4 6 4.4 6 4.4 6
Niacin (mg) 30 50.6 30 50.6 30 50.6 50.6
Pyridoxine (B6) (mg) 6 3.9 6 3.9 6 3.9 6
Folate (mg) 2 1.3 2 1.3 2 1.3 2
Vitamin B12 (µg) 25 11 25 11 25 11 25
Vitamin A (IU) 4000 4300 4000 4300 4000 4300 4300
Vitamin D (IU) 1000 391 1000 391 1000 1000 391
Vitamin E (IU) 75 24.6 75 24.6 75 24.6 24.6
Vitamin K (µg) 750 189 750 189 750 189 189
Choline (mg) 1027 648 1027 648 1027 648 1027
Abbreviations: AIN American Institution of Nutrition, TWD total Western diet, DIO diet-induced obesity, VMM
vitamin- and mineral-modified diet; MM macronutrient-modified diet; TWD + CaVD total Western diet with
restored calcium and vitamin D; TWD + MD total Western diet with restored methyl donor micronutrients B2, B6,
B12, choline and folate. Notes: Composition of the TWD was published previously [23]. No data are available in
NHANES for chloride, manganese, iodine, pantothenic acid, biotin, or ultra-trace minerals. Thus, levels of these
components in the AIN93G diet were used in the formulation of all experimental diets.
2.3. Experiment Designs
2.3.1. Experiment A: AOM + DSS Model of CAC with the TWD
To determine the impact of a diet that emulates Western nutrient intakes on CAC, we employed
the AOM + DSS mouse model using C57BL/6J mice. We hypothesized that exposure to the TWD
would promote colon tumorigenesis, and that this effect would be mediated, at least in part, by the
micronutrient faction of the diet. Experimental diets included (1) AIN93G, the standard basal diet
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routinely employed in rodent studies (AIN); (2) the total Western diet (TWD), as described in Hintze,
et al. [23]; (3) a macronutrient-modified diet (MM), which was modeled after the 50th percentile of
NHANES intakes (as with TWD), yet contained the same vitamin and mineral content as the AIN93G
diet; (4) a vitamin- and mineral-modified diet (VMM), which was modeled after the 50th percentile of
NHANES intakes for vitamins and minerals (as with TWD), yet contained the same macronutrient
content as the AIN93G diet; and (5) a commercial diet-induced obesity diet (DIO) that contained 45%
of energy as fat (primarily lard) and matched the AIN93G for micronutrient content. At 5 weeks of age,
male C57BL/6J mice were assigned to diet groups using a random block design to equalize group body
weight at the start of the study (n = 20 per diet group) (Figure S1). At 7 weeks of age, all mice were
dosed i.p. with 10 mg/kg AOM prepared in sterile PBS and provided 1% (w/v) DSS, a colonic irritant,
via their drinking water for 4 weeks followed by regular tap water for the remainder of the study. After
16 weeks, all mice were euthanized by CO2 asphyxiation and necropsied. Colons were isolated, flushed
with PBS, cut open longitudinally, and stored at 4 ◦C in 70% (v/v) ethanol until further assessment.
2.3.2. Experiment B: Restoration of Calcium and Vitamin D or Methyl Donor Micronutrients in TWD
to Amounts in the AIN Diet
In this follow-up experiment, we sought to determine whether restoring calcium and vitamin D
or methyl donor micronutrients that contribute to one-carbon metabolism to amounts present in the
standard AIN93G diet would suppress TWD-enhanced colon tumorigenesis. We hypothesized that
both modifications would reduce tumor multiplicity and tumor burden in mice fed TWD. Experimental
diets included (1) AIN93G, the standard basal diet routinely employed in rodent studies (AIN); (2) the
total Western diet (TWD), (3) the TWD with calcium and vitamin D concentrations restored to amounts
in the AIN diet (TWD + CaVD); and (4) the TWD with the methyl donor micronutrients B2, B6, B12,
choline and folate restored to amounts in the AIN diet (TWD + MD). At 5 weeks of age, male C57BL/6J
mice were assigned to diet groups using a random block design to equalize group body weight at the
start of the study (n = 30 per diet group) (Figure S1). On experiment day 21, all mice were dosed i.p.
with 10 mg/kg AOM prepared in PBS and provided 1% (w/v) DSS, a colonic irritant, via their drinking
water for 10 days followed by regular tap water for the remainder of the study. On experimental
days 33 and 45, mice were temporarily placed in new cages blinded to treatment and then the disease
activity index (DAI) was determined by summing four qualitative scores for symptoms of colitis,
including stool consistency (0, solid; 1, slightly soft; 2, moderately soft; 3, soft; 4, moderately liquid or
liquid), apparent blood in stool (0, none; 1, trace; 2, low amount; 3, moderate amount; 4, high amount),
apparent rectal bleeding (0, none; 1, trace; 2, low amount; 3, moderate amount; 4, high amount) and
weight loss since onset of DSS treatment. For scoring weight loss, the top of the scoring scale was
determined to be 1 SD below the average change in body weight of the AIN control group for either
the colitis or recovery time point (defined as top). Thus, weight loss scores were assigned as follows: 0,
> top; 1, top to −5%; 2, −5% to −10%; 3, −10% to −20%; 4, <−20%. This scaling allows for estimation of
the lack of weight gain as is appropriate for animals exposed to DSS during a period of rapid body
weight increase. Each parameter score was summed to calculate the DAI with a maximum possible
score of 20 for each individual animal. On day 112, all mice were euthanized by CO2 asphyxiation and
necropsied. Colons were isolated, flushed with PBS, cut open longitudinally, and stored at 4 ◦C in 70%
(v/v) ethanol until further assessment.
2.3.3. Experiment C: ApcMin/+ Model of Intestinal Tumorigenesis with TWD and DIO Diets
To determine whether the tumor-promoting effects of TWD were restricted to the colon or
to the AOM + DSS model of CAC, we next determined the impact of TWD using the ApcMin/+
genetic mouse model of intestinal tumorigenesis. Heterozygotes of this strain spontaneously develop
adenomas in the small intestine with high multiplicity, and inclusion of DSS in the treatment protocol
markedly enhances tumorigenesis in the colon within a similar study time frame. Male C57BL/6J-
ApcMin/+ and female wild type C57BL/6J-Apc+/+ mice were obtained from Jackson Laboratories (Bar
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Harbor, ME) and bred to produce either wildtype or ApcMin/+ offspring. At weaning, genotyping was
performed by modification of PCR by Su et al. [25] using DNA that was isolated from ear tissue by a
NaOH extraction method [26]. Apc-mutant (5′-TTCTGAGAAAGACAGAAGTTA-3′), Apc-wild-type
(5′-GCCATCCCTTCACGTTAG-3′), and Apc-common (5′-TTCCACTTTGGCATAAGGC-3′) primers
were used at concentrations of 250 nM, 42 nM, and 500 nM, respectively with AmpliTaq Gold® 360
Master Mix (Life Technologies, Grand Island, NY). PCR was performed using a thermocyling protocol
of 93 ◦C for 10 min; 40 cycles of 95 ◦C for 30 s, 55 ◦C for 30 s; 72 ◦C for 60 s; and a final extension of
72 ◦C for 3 min to generate amplicons 619 bp in length for both ApcMin/+ and Apc+/+ genotypes and
amplicons of 313 bp in length for ApcMin/+ genotype only. Amplicon size was verified by agarose gel
electrophoresis. Genotyped offspring were randomly assigned to one of three experimental diet groups,
AIN, TWD or DIO, with each group consisting of 20 male and 20 female ApcMin/+ mice (Figure S1). At 5
weeks of age, half the mice in each dietary group were administered DSS at 1% (w/v) via drinking water
for 10 days while the remaining half continued to receive normal tap water (final n = 10 males and 10
females for each diet/DSS subgroup). At 12 weeks of age, body composition was measured using an
MRI scan (EchoMRI-700; EchoMRI, Houston, TX), and then the mice euthanized by CO2 asphyxiation
and necropsied. The cecum, liver, kidneys, and spleen were weighed, immediately frozen in liquid
nitrogen, and stored at −80 ◦C. Small intestines and colons were isolated, flushed with PBS, cut open
longitudinally, and stored at 4 ◦C in 70% (v/v) ethanol until further assessment.
2.3.4. Experiment D: Longitudinal Effects of TWD on Colitis and Recovery from Gut Injury
In this experiment, we sought to investigate the impact of TWD over the course of disease
development as colitis progressed to colon tumorigenesis. We hypothesized that TWD exposure would
exacerbate symptoms of colitis and delay recovery after cessation of DSS exposure. Male C57BL/6J
mice were assigned to either AIN or TWD diet groups using a random block design to equalize group
body weight at the start of the study (n = 48 per group) (Figure S1). On study day 21, mice were dosed
i.p. with 10 mg/kg AOM and given 1% (w/v) DSS in the drinking water for 10 days. On study days 7, 32,
and 45, the colitis DAI was determined for all mice as described above and two cages (n = 8 per group
per time point) were randomly selected from each diet group for necropsy for histopathology (details
below). All remaining mice (n = 21 to 23 per group) were necropsied on day 105. Prior to necropsy,
body composition measurements were recorded by EchoMRI-700 (Houston, TX, USA). At necropsy,
body, liver, kidney, spleen, and cecum weights were recorded. Colons were isolated, flushed with
PBS, and cut open longitudinally. Randomly selected colon tissue samples were stored in 70% (v/v)
ethanol and assessed within 24 h of collection, then transferred to 10% phosphate-buffered formalin for
histopathology (details below). The remaining colon tissues were stored at 4 ◦C in 70% (v/v) ethanol
until further assessment.
2.3.5. Experiment E: Impact of TWD on DSS-induced Colitis and Expression of Immune- and
Cancer-Related Genes in the Colon
Last, we aimed to determine the molecular mechanisms underlying the promoting effects of the
TWD on colitis symptoms and the apparent delay in recovery following cessation of DSS-induced
gut injury using a targeted immune gene expression profiling approach. Male C57BL/6J mice were
assigned to either AIN or TWD diet groups using a random block design to equalize group body
weight at the start of the study (n = 24 per group) (Figure S1). On study day 21, mice were given 1%
(w/v) DSS in the drinking water for 10 days. On days 33 and 45, the colitis DAI was determined for all
mice as described above. On study days 21, 33, and 45, two cages (n = 8 per group per time point)
were randomly selected from each diet group for necropsy. Colons were isolated, flushed with PBS,
and cut open longitudinally to expose the intestinal mucosa. Colon mucosa samples were collected
by gentle scraping with a glass slide, immediately frozen in liquid nitrogen, and stored at −80 ◦C for
transcript analysis.
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2.4. Assessment of Tumors of the Colon or Small Intestine
To determine the effect of the experimental diets on tumorigenesis in the colon or the small
intestine (Experiment C only), tissues were stained with 0.1% (v/v) methylene blue in PBS and analyzed
under a dissecting microscope. The researcher was blinded to the sample identification at the time of
assessment. Measurements of colon length and tumor volumes were obtained using a pair of electronic
calipers. Colon tumors were identified and counted using the following criteria: (1) defined, generally
round or oval shape, (2) defined, easily distinguishable edges, and (3) lighter color with respect to
surrounding tissue. Tumor multiplicity was calculated as the number of tumors per mm colon for
each tumor-bearing animal. Colon tumor volume was estimated using the formula volume = pi/6(L ×
W × D), where L is the length, W is the width, and D is the depth of the tumor. Aberrant crypt foci
(ACF) in the colon were also identified in using criteria described previously [27,28]. Briefly, ACF
were characterized as crypts of larger size and often slit-shaped, with increased pericryptal area, and
thickened layer of epithelial cells which sometimes resulted in greater staining around the crypt. Small
intestine polyps were identified by the following criteria: (1) generally round with a floret or crater
appearance, (2) dark and solid in color, (3) firm and inflexible. Tumor multiplicity was calculated as the
number of tumors per mm small intestine for each tumor-bearing animal. Size of the small intestine
lesions was estimated using the formula area = pi/4(L ×W), where L is the length and W is the width.
2.5. Histopathology and Immunohistochemistry
Colons selected for histopathology assessment were stored using the Swiss-roll method for 24 h in
10% (v/v) formalin and then transferred to 70% (v/v) ethanol prior to embedding in paraffin. Microscopy
slides were prepared from 5 µm sections of the paraffin block and stained with hematoxylin and
eosin per standard protocol. These samples then were submitted to the Utah Veterinary Diagnostic
Laboratory for histopathological analysis by a board-certified pathologist. Tissues were blinded
as to treatment and then assessed for inflammation and mucosal injury using a grading scheme
previously described [29,30]. Sections were scored on a 0 to 4-point scale for three parameters:
inflammation/cellular infiltration, epithelial regeneration and crypt damage. For inflammation, severity
and depth were separately assessed, combined into one score, and then multiplied by a factor reflecting
the percentage of the colon involved (1, 0%–25%; 2, 26%–50%; 3, 51%–75%; and 4, 76%–100%) to obtain
the overall score. Assessment of the epithelium was evaluated by averaging the severity of crypt loss
or ulceration over at least 20 high power fields (400×; 4.74 mm2). For mucosal injury, crypt damage
and regeneration were also summed and multiplied by a factor reflecting the percentage of the colon
involved (as outlined above) to obtain an overall score.
Selected formalin-fixed paraffin-embedded sections of tissues from Experiment A were subject to
standard immunohistochemistry protocols recommended by the antibody supplier for detection of
beta-catenin and Ki67. Briefly, tissue sections (5 µm thick) were cut and antigen retrieval was achieved
by heating the sections in 10 mM sodium citrate with 0.05% (v/v) Tween-20 at pH 6.0 for 10 min in a
pressure cooker. Sections were then incubated as follows: 30 min with Background Punisher blocking
reagent (Biocare Medical); 30 min with primary antibodies for either anti-beta catenin (1:500 dilution;
biomarker of activation of the Wnt signaling pathway) or anti-Ki67 (1:50 dilution; biomarker of cell
proliferation); 30 min with rabbit-on-rodent HRP-polymer; 15 min with Warp RedTM chromagen
(Biocare Medical); and 5 min hematoxylin counterstain.
2.6. Analysis of Transcript Abundance Data for Colon Mucosa
Gene expression analyses of colon mucosa samples obtained from Experiment E were performed
largely as described previously [31], with some modifications outlined below. Total RNA was
extracted from the total colon mucosa with TriReagent (Sigma Aldrich, St. Louis, MO, USA) per
manufacturer’s instructions. Resultant RNA was further purified and genomic DNA removed
by RNeasy Mini Kit with DNase treatment (Qiagen, Valencia, CA, USA). RNA was dissolved in
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nuclease-free water and quantified using Qubit (Thermo Fisher), and RNA purity was verified by
determining 260/280 and 260/230 absorbance ratios by NanoDrop Spectrophotometer (NanoDrop 1000,
Wilmington, DE). RNA (n = 6–8/group) was analyzed using the nCounter Mouse PanCancer Immune
Profiling Panel (NanoString Technologies, Seattle, WA, USA), which includes 750 immune-related
genes, 20 housekeeping genes, 6 positive controls and 8 negative controls. Assays were performed and
quantified on the nCounter MAX system, sample preparation station, and digital analyzer (NanoString
Technologies) according to the manufacturer’s instructions. Briefly, reporter and capture probes were
hybridized to target analytes for 16 h at 65 ◦C. After hybridization, samples were washed to remove
excess probes. Then, the purified target-probe complexes were aligned and immobilized onto the
nCounter cartridge, and the transcripts were counted via detection of the fluorescent barcodes within
the reporter probe. Probe annotations are provided in File S1.
Raw gene expression data were analyzed using NanoString’s software nSolver v3.0.22 with the
Advanced Analysis Module v2.0. Background subtraction was performed using the eight included
negative controls included with the module. Genes with counts below a threshold of 2σ of the mean
background signal were excluded from subsequent analysis. Data normalization was performed on
background-subtracted samples using internal positive controls and selected housekeeping genes
that were identified with the geNorm algorithm (https://genorm.cmgg.be/). Ratios of transcript count
data for all diets and time points were generated using the AIN diet group at the Pre-DSS time
point (AIN/Pre-DSS) as a reference. Ratios were then log2 transformed for downstream analysis and
data presentation.
Differential gene expression analyses were performed using the nSolver Advanced Analysis
Module, which employs several multivariate linear regression models (mixture negative binomial,
simplified negative binomial, or log-linear model) to identify significant genes. Resulting p values were
adjusted using the Benjamini–Hochberg (BH) method to control the false discovery rate. A statistically
significant difference in gene expression was defined as two-fold change in expression (log2 > 1 or
< −1) with BH q < 0.05. Nine pairwise comparisons were determined a priori, as follows: (1) colitis
vs. pre-DSS fed AIN; (2) recovery vs. pre-DSS fed AIN; (3) recovery vs. colitis fed AIN; (4) colitis vs.
pre-DSS fed TWD; (5) recovery vs. pre-DSS fed TWD; (6) recovery vs. colitis fed TWD; (7) TWD vs.
AIN at pre-DSS time point; (8) TWD vs. AIN at colitis time point; and (9) TWD vs. AIN at recovery time
point. Outputs from nSolver differential expression analysis are provided in File S2. Venn diagrams of
significant differentially expressed genes were generated using BioVenn [32].
To assess the impact of experimental diets on annotated gene sets, global and directed significance
scores were calculated for each pathway at each time point. The global significance score for each
gene set was calculated as the square root of the mean squared t-statistic of genes, as determined
by the differential gene expression analyses. The global score estimates the cumulative evidence for
the differential expression of genes in a pathway. The directed significance score was also calculated
by considering the sign of the t-statistics. Directed significance scores near zero indicate that a
pathway may have many highly regulated genes, but no apparent tendency for those genes to be
over- or under-expressed collectively. As a complementary method for comparing pathways and
discriminating between experimental groups, pathway Z scores were calculated as the Z-scaled first
principal component of the pathway genes’ normalized expression. Files S3-S4 provide summary
tables for all significance and pathway Z scores, respectively. ClustVis [33] was used to perform
unsupervised hierarchical cluster analyses (HCC) and principal components analyses (PCA) using
log2 transcript count data for differentially expressed genes. Finally, Spearman rank correlations were
performed to examine overall patterns in the gene expression profiles using the pathway Z score
compared to the observed DAI at the colitis and recovery time points. A significant correlation was
inferred when ρ > 0.5 or < −0.5 and p < 0.05. Network analyses for interactions among significant
genes were performed using STRING database version 10.5 (http://string-db.org/), which curates
both experimental and predicted gene interactions. Only interactions among significant DEGs were
considered with the confidence level for associations set at ≥ 0.9. Clusters were identified using the
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Markov Cluster (MCL) algorithm with inflation parameter of 1.5. Networks generated by STRING
were visualized with Cytoscape v. 3.5. File S5 provides data for STRING-db networks and the predicted
clusters. The PathView module in nSolver was used to overlay differential expression analyses results
with KEGG pathways for visualization of differentially expressed genes in context of relevant biological
pathways. To determine which biological processes were associated with DEGs for either AIN or TWD
at either colitis or recovery time points, gene ontology enrichment was performed using the complete
set of detected genes as the background list (Metascape, [34]). A significant enrichment in biological
process terms associated with lists if DEGs was inferred when FDR q < 0.05 and enrichment was at
minimum 1.5. Redundant terms were clustered by similarity (kappa score > 0.3), and the term with
the most significant q-value within a cluster was used to identify that cluster. Complete gene ontology
results from Metascape are provided in File S6.
The NanoString nSolver Advanced Analysis software employs the method described by
Danaher [35] to measure the abundance of various immune cell populations using marker genes that are
expressed stably and specifically in particular cell types. Cell type scores were calculated as the average
log-scale normalized expression of their characteristic genes. Relative cell type measurements were
based on the total population of infiltrating lymphocytes, which is useful in a sample of heterogenous
mix of cell types. While this analysis did not convey information on the absolute number of immune
cells in any one sample, comparisons were made within each cell type across test diets and time points.
Only cell types that exceeded the quality control analysis for correlation of marker gene expression are
reported herein, including the following cell types and their marker genes: B-cells (Ms4a1, Tnfrsf17),
T-cells (Cd3d, Cd3e, Cd3g, Cd6, Sh2d1a), CD8 T-cells (Cd8a, Cd8b1), dendritic cells (Ccl2, Cd209e, Hsd11b1),
neutrophils (Csf3r, Fcgr4), and CD45 (Ptrpc). File S7 provides both the raw and relative cell type scores
calculated by nSolver software.
2.7. General Data Analysis
Statistical analyses for tumor incidence were performed using the Fisher’s exact test, followed by
a Bonferroni adjustment to correct for multiple testing (Prism v. 8, GraphPad Software, San Diego,
CA). Other data were analyzed using a linear mixed model for main effects of diet, time point, and/or
sex (experiment C only) with cage as a nested, random factor using the restricted maximum likelihood
(REML) estimation and the Tukey HSD post-hoc test for multiple comparisons (JMP v. 12, SAS Institute,
Cary, NC). Suspected outliers were verified using the robust outlier test (ROUT) with a conservative Q
value of 1% (Prism), meaning that there was ≤1% chance of excluding a data point as an outlier in error.
Data that did not meet the equal variance assumption were log10 or sqrt transformed. For data that were
not normally distributed or for which a transformation did not equalize variance, the non-parametric
Steel–Dwass test was used (JMP). A significant effect of the test variable was inferred when the adjusted
p value was < 0.05. Energy intakes were assessed on a per cage basis.
3. Results
3.1. Experiment A: AOM + DSS Model of CAC with the TWD
In this first experiment, we tested the TWD in comparison to the standard AIN93G diet designed
to sustain rodent health and the 45% fat DIO diet commonly used to induce obesity in C57BL/6J male
mice. To determine the contribution of macro- or micronutrients on cancer outcomes, we also split the
TWD into its macro- (MM diet) or micronutrient (VMM) fractions. As expected with this initiation
protocol, nearly all animals acquired colon cancer. When correcting for multiple testing, no significant
differences were noted among the diet groups for colon tumor incidence (Figure 1A).
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determined by the appropriate linear mixed model or nonparametric test as outlined in the Materials
and Methods. For multiplicity data segregated by tumor size (E), data were stratified by tumor size
prior to statistical analyses. (I) Gross pathology images depicting colon tissues representative of
each diet treatment group as follows: i, AIN, ii, TWD; iii, VMM; iv, MM, and v, DIO. White arrows
indicate large colon tumors easily visible via low magnification light microscopy. (J) H&E staining of
colon tissues depicting different stages of disease, as follows: i, normal (400×); ii, mild inflammation
(infiltration of neutrophils, lymphocytes and plasma cells in the submucosa, yellow arrow) (400×); iii,
moderate inflammation (infiltration of neutrophils, lymphocytes and plasma cells in the submucosa,
yellow arrow) (400×); iv, healed mucosal ulcer with complete loss of colonic glands and neutrophilic
and lymphoplasmacytic inflammation (black arrow) (200×); v, gastrointestinal intraepithelial neoplasia
(GIN, blue arrow) alongside normal tissue (white arrow) (100×); vi, GIN (blue arrow) (400×); vii, high
grade adenoma (×) (20×); viii, high grade adenoma (×) (400×). (K) Expression of ki-67 in colon tissues:
(i) normal (white arrow) and GIN (blue arrow) (200×), (ii) high grade adenoma (×) (200×); (iii) high
grade adenoma (×) (100×). (L) Expression of beta catenin colon tissues: (i) normal colon (400×); (ii),
adenoma (*) (400×); (iii) high-grade adenoma (×) (40×). Scale bars = 200 µm.
On the other hand, striking significant effects of experimental diet on tumor multiplicity and size
were observed. Mice provided either the TWD or VMM diets had nearly twice as many tumors as their
AIN-fed counterparts (p = 0.0338 or p = 0.0024, respectively), and about 3-times the number of tumors
as animals provided the MM or DIO diets (p < 0.0001) (Figure 2B). However, tumor multiplicity was
not significantly different in animals fed the MM or DIO diets compared to the AIN93G group. A very
similar pattern for tumor volume was also evident, as the average tumor size in mice provided TWD or
VMM diets was about 3.6- to 2.5-fold higher than in mice fed AIN diet (p < 0.005) (Figure 1C). An even
more pronounced, 10-fold increase in average tumor size was observed when comparing the TWD and
VMM groups to mice fed either the MM or DIO diets (p < 0.0001). Moreover, the tumor burden (defined
as the total volume of tumor tissue) in mice fed TWD and VMM was markedly higher compared to
their counterparts fed AIN (p ≤ 0.0001). These differences in CAC outcome between dietary treatments
were apparent in tumors sized between 1 and 3 mm but not larger (< 3 mm) or smaller (> 1 mm)
tumors (Figure 1E). Thus, in terms of overall CRC phenotype, mice fed the VMM diets were most
similar to mice fed the TWD, while MM fed mice were most similar to mice fed AIN and DIO diets.
To determine whether mice fed MM or DIO diets acquired a large number of preneoplastic lesions that
failed to progress to tumors, we counted the number of aberrant crypt foci (ACF) and the average
number of aberrant crypts (Figure 1F,G). Although no significant differences among diet groups were
observed, the low variance evident in mice fed the TWD and VMM likely reflects that many of the
preneoplastic lesions in these diet groups progressed to form colon tumors. Not surprisingly, dietary
treatment resulted in a pattern of gut inflammation that corresponded to CAC outcome. Mice fed the
TWD and VMM diets had increased histological inflammation scores relative to all other treatments
(p < 0.05) (Figure 1H).
Tumors were readily apparent via gross examination of colon tissues, with very large tumors
evident in mice fed TWD or VMM diets (Figure 1G). Histologic assessment of H&E-stained tissue
sections revealed evidence of mild multifocal lymphoplasmacytic colitis and presence of colon
adenomas (low and high grade) in some tissues from AIN-fed mice, as expected for the AOM +
DSS model of CAC. In mice fed TWD or VMM diets, histologic analysis typically revealed multiple
high-grade tubular colonic adenomas, gastrointestinal intraepithelial neoplasia (GIN), and moderate
lymphoplasmacytic multifocal colitis. In mice fed DIO or MM diets, minimal or mild multifocal
lymphoplasmacytic colitis was noted with no tumors observed microscopically in the tissues examined.
Example tissue sections stained with H&E, probed for beta-catenin expression, or probed for Ki67
expression that typify these histological features (e.g., colitis, GIN and adenoma) are provided in
Figure 1J–L.
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Figure 2. Restoration of calcium and vitamin D to amounts in the AIN diet suppressed colitis symptoms
and inflammation-associated colon tumorigenesis in C57BL/6J male mice fed TWD (Experiment B). Diet
groups included the standard AIN93G iet (AIN), the total Western diet (TWD), the TWD with calcium
and vitamin D restored to AIN amounts (TWD + CaVD) or the TWD with methyl donor micronutrients
B2, B6, B12, folate, and choline restored to AIN amounts (TWD + MD). (A) Colitis disease activity index
(D I) score (n = 29 to 32) at colitis and recovery time points. (B–E) Colon tumor outcomes include
incidence (B), tumor multiplicity (C), average tumor volume per mouse (D), and burden as total tumor
volume (E) (n = 23 to 26). Data in all panels (except B) are shown as Tukey box plots (box, 25th to 75th
percentiles; whiskers, 1.5 IQR; +, mean). Different letters indicate that treatment groups are significantly
different (p < 0.05) as determined by the appropriate linear mixed model or nonparametric test as
outlined in the Materials and Methods.
During this study, we monitored food and energy intake and body weight gain. We previously
reported the impacts of these experimental diets on body weight, body composition, glucose tolerance
and other measures related to metabolic syndrome for sham-initiated mice [see results in 36]. Energy
intake in AOM-initiated mice was not significantly different for mice fed AIN, TWD, VMM or MM diets,
whereas DIO-fed mice consumed substantially more food energy (Figure S2A). This excess energy
intake translated to a substantial increase in average body weight for DIO-fed mice at the end of the
study. Similarly, mean body weight was also increased for mice fed MM diet (Figure S2B). However,
mice fed TWD and VMM did not gain more weight, reflecting their overall normalized energy intake.
At the end of the study, colon length was not notably correlated with evidence of inflammation or
tumorigenesis, as the only noted difference was between the VMM and DIO diet groups (Figure S2D).
3.2. Experiment B: Restoration of Calcium and Vitamin D or Methyl Donor Micronutrients in TWD to
Amounts in the AIN Diet
To determine which micronutrients might be responsible for the differential CAC response
between mice fed the AIN and TWD in the previous experiment, modifications were made to the
micronutrient portion of the TWD. We hypothesized, based on previous work from Newmark and
colleagues [18–20], that suboptimal concentrations of calcium and vitamin D or methyl donors in
the TWD were responsible for enhanced colon tumorigenesis. Therefore, experimental diets were
formulated that included: the TWD + dietary calcium and vitamin D at the same a ount as AIN93G
diet (TWD + CaVD) and TWD + dietary methyl donors at the same amount as AIN93G diet (TWD +
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MD, Figure S1). During active colitis, mice fed TWD had nearly 2-fold higher DAI score (p < 0.0001)
than those fed AIN (Figure 2A), and this effect persisted to recovery (Figure 2B). Restoration of calcium
and vitamin D to amounts present in the AIN diet appeared to suppress the DAI during colitis and
recovery such that symptoms were not different from the AIN diet group (p = 0.2313). Alternatively,
colitis symptoms were not significantly changed in mice fed TWD + MD as compared to either TWD or
AIN diets (Figure 2A). Colon tumor incidence was not different among any of the test diets. However,
as observed in the prior experiment, consumption of the TWD significantly increased colon tumor
multiplicity (p = 0.0099) and burden (p = 0.0264); although tumor volume was greater in TWD-fed
mice, this response was highly variable and not significantly different from AIN-fed animals. Of note,
the tumor response in mice fed the TWD + CaVD diet mirrored earlier observations for DAI in this
model of CAC, with significant decreases in tumor multiplicity (p = 0.0314) and tumor burden (p =
0.0306) evident compared to TWD-fed mice (Figure 2C–E). These observations suggest that addition
of calcium and vitamin D back to the TWD was sufficient to rescue the carcinogenic phenotype of
the TWD. Conversely, supplementation of the TWD with methyl donor micronutrients had a more
moderate effect on these endpoints, as the tumor response in mice fed TWD + MD was not significantly
different compared to the either the AIN or TWD treatments for any of these measures (Figure 2C–E).
Mice fed the TWD + CaVD diet consumed more energy than did their counterparts fed AIN or
TWD (p < 0.05), but not more than those fed TWD + MD (Figure S3A). However, the only apparent
difference in final body weight was noted when comparing AIN-fed mice to those provided TWD
+ CaVD (Figure S3B). In this experiment, the body composition of mice in any group provided the
TWD basal diet was significantly shifted toward fat as compared to those fed the AIN diet, which was
entirely attributed to a gain in fat mass (Figure S3C) as opposed to a loss of lean mass (Figure S3E).
Cecum weights did not differ among mice fed the different TWD diets, however, mice fed the AIN diet
had larger ceca than the TWD fed mice (Figure S3G). Dietary treatment did not affect colon length at
necropsy (Figure S3H).
3.3. Experiment C: ApcMin/+ Model of Colorectal Carcinogenesis with TWD and DIO Diets
In order to determine if the tumorigenesis response to TWD was limited to the AOM + DSS
model, ApcMin/+ mice were fed the AIN, TWD or DIO diets with and without DSS. For all dietary
treatments, addition of DSS to drinking water resulted in a higher incidence of colon tumors (p <
0.05). Of note, for mice provided DSS, those fed TWD had significantly greater incidence compared to
their counterparts fed either AIN or DIO diets (p = 0.0163 and 0.0193, respectively). For colon tumor
multiplicity and burden, the experimental diet and DSS treatments were significant factors (main effect
p < 0.0001) in the mixed model, and a significant interaction was also noted (p < 0.0001) as clearly
demonstrated by the very robust tumorigenesis response observed in mice fed TWD and provided DSS
to trigger inflammation (Figure 3B,D). Average tumor multiplicity in TWD-fed, DSS-treated ApcMin/+
mice was nearly 70- to 100-fold greater (2.55 ± 0.032 tumors/mm) compared to their counterparts
fed AIN (0.038 ± 0.0072 tumors/mm) or DIO (0.024 ± 0.0053 tumors/mm) (p = 0.0018 and =0.0002,
respectively). A similar pattern was noted for tumor burden (Figure 3D), but interestingly, tumor
size was not affected by diet or DSS treatment (Figure 3C). Mouse sex was not a significant factor for
any colon tumor parameter assessed. The small intestine tumor phenotype was marginally affected
by dietary treatment (main effect p = 0.0491), but not by DSS or sex. Incidence of small intestine
tumors was 100%, as anticipated for this model (Figure 3E). Mice fed the DIO diet had increased tumor
multiplicity and burden relative to AIN but not TWD fed mice (Figure 3F,H), although tumor size was
marginally greater in mice fed TWD compared to their counterparts (Figure 3G). Representative colons
from animals fed either AIN, TWD, or DIO with or without DSS treatment are presented in Figure 3J.
Note that large colon tumors were easily visible via low magnification light microscopy in mice fed the
TWD, whereas few tumors were evident in mice fed AIN or DIO diets and provided DSS, or for mice
provided plain drinking water.
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Figure 3. TWD promotes inflammation-associated colon tumorigenesis in ApcMin/+ mice, but does not
markedly alter small intestine tumor development (Experiment C). ApcMin/+ female and male mice
were fed a standard diet (AIN), the total Western diet (TWD) or the 45% fat diet-induced obesity
diet (DIO) for 12 weeks. Half the mice were provided 1% DSS via drinking water for two weeks.
(A) Incidence of colon tumors shown as the percent of mice with tumors. * p < 0.05, *** p < 0.001 for
comparisons of DSS to CON group within each diet and # p < 0.05 for comparison across diet groups
within CON or DSS cohorts as determined by the Chi-square test. (B–D) Data shown include colon
tumor multiplicity (B), average size of colon tumors (as volume) (C) and colon tumor burden (as total
volume) (D). (E) Incidence of small intestine tumors shown as the percent of mice with tumors. (F–H)
Data shown indicate small intestine (SI) tumorigenesis endpoints for diet and DSS treatment, including
SI tumor multiplicity (F), average size of SI tumors (as area) (G), and burden of SI tumors (as total area)
(H). Data in B–D and F–H are shown as Tukey box plots (box, 25th to 75th percentiles; whiskers, 1.5
IQR; +, mean) (n = 18 to 22). Different letters indicate that groups are significantly different (p < 0.05)
as determined by the appropriate linear mixed model or nonparametric test. For SI tumor outcomes,
comparisons were made by diet group only as no main effect of or interaction with DSS was observed.
(I) Main effect p-values for diet, DSS treatment, sex and all possible interactions are indicated to the
right of charts for colon tumor data (top) or SI data (bottom). (J) Gross pathology images depicting
colon tissues representative of each diet treatment group as follows: i, AIN and no DSS; ii, AIN+DSS;
iii, TWD and no DSS; iv, TWD+DSS; v, DIO and no DSS; vi, DIO+DSS. White arrows indicate large
colon tumors easily visible via low magnification light microscopy.
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Dietary treatment had no effect on energy intake, although male mice fed TWD had a marginally
higher average final body weight compared to their counterparts fed AIN or DIO diets (Figure S4).
Fat and lean mass distribution was also affected by dietary treatment. Female TWD-fed mice had a
higher relative fat mass and corresponding lower relative lean mass compared to AIN- or DIO-fed
females, whereas male DIO-fed mice had higher relative fat mass and corresponding lower lean mass
(Figure S4C,D). Similar to the previous experiment, the cecum weight was greater in AIN-fed mice
compared to those provided TWD, but not the DIO diet (Figure S4E). Although colon length at necropsy
was largely unaffected by dietary or DSS treatment, a main effect of sex was noted (p = 0.0179) with
colon length slightly longer in males (69.2 ± 0.99 mm) than females (65.7 ± 0.79 mm) (Figure S4F).
An interaction between diet and DSS treatment was also noted for colon length, driven apparently by a
significant difference in mice fed TWD with plain water compared to mice fed DIO with DSS, although
this comparison was not of primary interest (Figure S4F).
3.4. Experiment D: Longitudinal Effects of TWD on Colitis and Recovery from Gut Injury
Next, we performed a longitudinal study comparing the colitis and carcinogenesis phenotype in
mice fed either the TWD or AIN diets before DSS treatment, during active colitis, during recovery, and
at the study end using the AOM + DSS model. Exposure to the TWD markedly increased symptoms of
colitis throughout the study (Figure 4A). The histologic inflammation score was also increased for all
time points after DSS treatment in mice fed the TWD, while the mucosal injury score was elevated
during colitis and into recovery after cessation of DSS (Figure 4B,C) (P > 0.05, Figure 4B). We also
observed that the colon length was significantly shorter for mice fed TWD prior to DSS treatment,
through colitis and into recovery (Figure 4D); however, by the end of the study, the effect of diet on
colon length was not evident. Furthermore, cecum weight was lower in the TWD fed mice at the
colitis and recovery timepoints (Figure 4E). At the study end, tumor outcomes were largely similar
to observations from prior experiments, with TWD markedly increasing tumor multiplicity, average
tumor volume and tumor burden (p < 0.0001) relative to AIN-fed mice.
Representative histologic images depicting H&E-stained colon tissues at each disease stage are
provided in Figure 5. Prior to DSS treatment, the colonic epithelium of AIN- and TWD-fed mice
was intact with only mild multifocal inflammation evident in the mucosa in some mice. Following
AOM/DSS initiation during active colitis, the colonic mucosa of AIN-fed mice was typified by mild to
moderate multifocal neutrophilic infiltration (Figure 5D), whereas moderate to severe inflammation,
extensive crypt and surface epithelium loss, and little tissue regeneration were evident in the colon
tissues of TWD-fed mice (Figure 5E,F). Fourteen days later during recovery from gut injury, colons
of AIN-fed mice showed signs of regeneration with only mild-to-moderate inflammation present
(Figure 5G). However, for mice fed TWD, tissue regeneration was poor, with evidence of gastrointestinal
intraepithelial neoplasia and persistent extensive neutrophilic inflammation (Figure 5H,I). By the study
end, tissue of mice fed AIN was largely similar to that prior to the DSS exposure, with mild multifocal
inflammation (Figure 5J) (no adenomas were observed in the mice subject to histopathology in AIN-fed
mice at recovery, although some were seen macroscopically in other mice belonging to this group).
Alternatively, by the end of the study, all TWD-fed mice that were examined by histology were had
extensive neoplasia, including gastrointestinal intraepithelial neoplasia, adenoma, and high-grade
tubular adenoma and/or adenocarcinoma (Figure 5K,L).
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(H) and burden as the total tumor volume (I). Data in all panels (except F) are shown as Tukey box 
plots (box, 25th to 75th percentiles; whiskers, 1.5 IQR; +, mean). * p < 0.05; ** p < 0.01; *** p < 0.001; **** 
p < 0.0001 for TWD compared to AIN diet as determined by linear mixed model analyses for diet by 
time point with LS Means Student’s t-test post-hoc test between AIN and TWD diet groups. (J) Main 
effect p-values for diet, DSS treatment, sex and all possible interactions are shown for DAI score, 
inflammation score, mucosal injury score, colon length and cecum weight. 
. Consu ti of T enhance sy t s of colitis, colon infla ati a ucos inj r
i t ). /
i t r i f r 0 s t tri ger colon infla ation.
, . , t l
i fl i l i j . ( , ) l l t ( ) a cec i t
( ) (n = 7-8 for pre-DSS, colitis and recove y; n = 20-23 at terminal time point). (F–I) C lon tumorigenesis
outc mes, including incidence (F), multiplicity (G), average tumor volume per mouse (H) and burden
as the total tumor volume (I). Data in all panels (except F) are shown as Tukey box plots (box, 25th to
75th percentiles; whiskers, 1.5 IQR; +, mean). * p < 0.05; ** p < 0.01; *** p < 0.001; **** p 0.0001 for
TWD compared to AIN diet as determined by linear mixed model analyses for diet by time point with
LS Means Student’s t-test post-hoc test between AIN and TWD diet groups. (J) Main effect p-values
for diet, DSS treatment, sex and all possible interactions are shown for DAI score, inflammation score,
mucosal injury score, colon length and cecum weight.
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mild lymphoplasmacytic and neutrophilic mucosal inflammation (200×); (H,I) Gastrointestinal 
intraepithelial neoplasia (blue arrow) (H, 100x; I, 400×); (J) normal colonic mucosa (200×); (K) colon 
adenoma (A) at low magnification (40×); and (L) colon adenoma (Ad) at high magnification (400×). 
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point was notably diminished in AIN-fed mice as compared to pre-DSS, with only 143 DEGs 
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of TWD led to a prolonged transcriptional response of immune-related genes, with 305 DEGs 
identified at recovery compared to pre-DSS. Of note, relatively few DEGs were identified for mice 
fed either diet when comparing recovery to the colitis time point, although a comparison of TWD-
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Figure 5. Histology of colonic tissues during the course of disease development. Representative
images depicting H&E staining of colon tissues in mice fed AIN or TWD diets obtained prior to DSS
treatment (A–C), during active colitis (D–F), during recovery from gut injury (G–I) and at the study end
(J–L). Descriptions of tissue histology and image magnification: (A) normal colon (200×); (B) normal
colon with occasional mild multifocal lymphocytic inflammation (white arrow) and gut-associated
lymphoid tissue (black arrow) (200×); (C) normal colon (200×); (D) neutrophilic and lymphoplasmacytic
colitis with inflammation in the mucosa and submucosa (white arrow) (400×); (E,F) neutrophilic and
lymphoplasmacytic colitis with inflammation of the mucosa and submucosa (white arrow), mucosal
ulceration (orange arrow), and loss of glands (E, 200×; F, 400×); (G) colon with mild lymphoplasmacytic
and neutrophilic mucosal inflammation (200×); (H,I) Gastrointestinal intraepithelial neoplasia (blue
arrow) (H, 100x; I, 400×); (J) normal colonic mucosa (200×); (K) colon adenoma (A) at low magnification
(40×); and (L) colon adenoma (Ad) at high magnification (400×). Scale bar = 100 µm.
Lastly, in this experiment, dietary treatment did not significantly affect energy intake, body weight,
or body composition (Figure S5).
3.5. Experiment E: Immune- and Cancer-Related Gene Expression and cell Types in Colon Mucosa of
TWD-fed Mice
To determ e how exposure to the TWD exacerbates colitis and, subsequently, promotes colon
tumor genesis in mice, we d termined the dynamic expression of 750 immune- an ca ce -related
genes in colon ucosa samples obtained prior to DSS insult, during active olitis and during recov y
from co itis from mice f d either AIN or TWD. In Experiment E, DSS-induced colitis symptoms were
mark dly w rse in mice fed TWD compared to those fed AIN (Figure 6A). However, his effect did
not persist to the recovery ime point as was previously observed for animals initiated with both
AOM and DSS, suggesting that the unresolved i crease in inflammation wa due to the interaction
of the carcinogen and irritant. Comparison of gene expression in colon ti ues from AIN-fed mice at
colitis compared to pre-DSS time point reveal 244 differ ntially expressed genes (DEGs), while a
substant ally larger number of DEGs were noted in TWD-fed mic (Figure 6B,C), including 212 that
were uniquely impacted by TWD (Figure 6D). Immune-rel te gene sponse a the recovery time
poi was notably diminished in AIN-fed mice as compared to pre-DSS, with only 143 DEGs identified
and the bulk of those overlapped with c litis- sive genes. In contrast, con umption of TWD
led to a prolonged transcriptional response of immune-related genes, with 305 DEGs identified at
r covery compared to pre-DSS. Of not , relativ ly few DEGs were identified for ice fed either diet
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when comparing recovery to the colitis time point, although a comparison of TWD-fed to AIN-fed
mice at recovery revealed 48 genes that were uniquely expressed in response to TWD (Figure 6C.iii).Nutrients 2020, 12, x FOR PEER REVIEW 18 of 35 
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each comparison indicated plotted against the -log10 of the Benjamini–Hochberg FDR q value. A 
significant difference in gene expression was inferred for genes with BH q value < 0.05 and log2 ratio 
> 1 or < −1. (C) Number of significant differentially expressed genes across time points within each 
diet or comparing AIN vs. TWD at each time point. (D) Proportional Venn diagrams depicting the 
number of genes identified as differentially expressed in colon tissues of mice fed either AIN or TWD 
diets. Comparisons were made by time point for AIN diet (i), by time point for TWD diet (ii), or by 
diet at each time point (iii). 
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by unsupervised, bi-directional hierarchical clustering of DEGs at each time point (Figure 7B), with 
noticeable segregation of expression profiles by diet group at colitis and marked separation at 
recovery. Figure S7 shows both PCA and hierarchical clustering for all DEGs across all time points as 
single plots, revealing distinct patterns of immune-related gene expression for pre-DSS and other 
time points and some separation of TWD- and AIN-fed mice at colitis and recovery. 
Only a few DEGs were identified in mice fed TWD prior to DSS treatment, including Ifit2, Ifit 3 
and Nlrc5, all three of which are involved in interferon response (Figure 7C). At colitis and recovery, 
DEGs were associated with antigen processing, adaptive immune responses, innate immune 
responses, T-cell function, CD molecules, interferon and MHC pathways (Figures 6C). Expression 
heatmaps depicting DEGs for these pathways are provided in Figures S8 and S9. Global and directed 
pathway significance scores showed that responses to TWD were markedly greater for both colitis 
Figure 6. Expression of immune and cancer pathway genes in colon tissues was impacted to a greater
extent in mice fed TWD as compared to those fed AIN during colitis and recovery (Experiment E).
(A) Disease activity index (DAI) for mice fed AIN or TWD and given DSS to induce gut inflammation
at colitis and recovery time points. (B) Volcano plots depicting immune-related mRNA expression
as measured using the NanoString Mouse PanCancer Immune panel. Values shown are log2 ratios
for each comparison indicated plotted against the -log10 of the Benjamini–Hochberg FDR q value.
A significant difference in gene expression was inferred for genes with BH q value < 0.05 and log2 ratio
> 1 or < −1. (C) Number of significant differentially expressed genes across time points within each
diet or comparing AIN vs. TWD at each time point. (D) Proportional Venn diagrams depicting the
number of genes identified as differentially expressed in colon tissues of mice fed either AIN or TWD
diets. Comparisons were made by time point for AIN diet (i), by time point for TWD diet (ii), or by diet
at each time point (iii).
Principal components analyses of DEGs at each time point indicated that the transcriptional
responses in colon mucosa of TWD-exposed mice were moderately distinct from those fed AIN
at colitis, but were highly divergent at the recovery time point (Figure 7A). Similar results were
obtained by unsupervised, bi-directional hierarchical clustering of DEGs at each time point (Figure 7B),
with noticeable segregation of expression profiles by diet group at colitis and marked separation at
recovery. Figure S7 shows both PCA and hierarchical clustering for all DEGs across all time points as
single plots, revealing distinct patterns of immune-related gene expression for pre-DSS and other time
points and some separation of TWD- and AIN-fed mice at colitis and recovery.
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time point, all genes differently expressed by at least two-fold with an FDR p < 0.10 were used for the 
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Figure 7. Exposure to the TWD prior to, during and after DSS-induced gut injury intensified changes
in expression of genes associated with immune and cancer pathways as compared to mice fed AIN
(Experiment E). (A) Principal components analyses (PCA) of differentially expressed genes (BH q <
0.05, log2 ratio > 1 or < −1) in colon tissues of mice fed either AIN or TWD prior to DSS (Pre-DSS),
during active colitis (Colitis), or two weeks later during recovery (Recovery). PC1 and PC2 are shown
with the 95% prediction ellipse. Because only three genes met all significance criteria at the Pre-DSS
time point, all genes differently expressed by at least two-fold with an FDR p < 0.10 were used for the
PCA analysis for that time point only. (B) Unsupervised, bidirectional hierarchical cluster analysis of
colon transcriptome data using the Euclidean distance method with average linkage. For each time
point, the heatmap shows all genes differentially expressed between TWD and AIN diet groups colored
by the log2 ratio calculated with respect to AIN/Pre-DSS. (C) Bar charts indicate the number of genes
differentially expressed at each time point for selected immune and cancer pathways. The total number
of genes affiliated with each pathway for the PanCancer Immune panel are indicated in parentheses.
Only a few DEGs were identified in mice fed TWD prior to DSS treatment, including Ifit2, Ifit 3 and
Nlrc5, all three of which are involved in interferon response (Figure 7C). At colitis and recovery, DEGs
were associated with antigen processing, adaptive immune responses, innate immune responses, T-cell
function, CD molecules, interferon and MHC pathways (Figure 6C). Expression heatmaps depicting
DEGs for these pathways are provided in Figures S8 and S9. Global and directed pathway significance
scores showed that responses to TWD were markedly greater for both colitis vs. pre-DSS and recovery
vs. pre-DSS comparisons with most pathways activated by TWD exposure (Figure S10). Similar results
were obtained when pathway-specific transcript abundance was analyzed as the Z-scaled first principal
component (the pathway Z score). Affected genes were associated with multiple immune and cancer
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pathways, including CD molecules, T-cell functions, cytokines and receptors, and adaptive and innate
immunity (Figure 7A). Of note, several pathways appeared differentially regulated by TWD at the
pre-DSS time point, including antigen processing, CD molecules, interferon, MHC and T-cell functions,
suggesting that the pathway response overall was divergent from AIN, even though few DEGs were
identified using the selected FDR and fold change criteria. Pathway Z scores were strongly correlated
with the DAI index, most notably for adaptive, CD molecules, cytokines and receptors, inflammation,




Figure 8. Pathway Z scores indicate broad scale changes in transcript abundance for genes associated 
multiple immune and cancer pathways that are also highly correlated with the colitis DAI. (A) Colon 
tissue gene expression pathway Z scores at Pre-DSS, colitis and recovery time points for mice fed AIN 
or TWD diets. Scores are shown as Tukey box plots (n = 6 to 8) for selected immune and cancer 
pathways. * p < 0.05 and ** p < 0.01 compared to time point-matched AIN control as determined by 
the non-parametric Steel-Dwass test. (B) Correlation analyses of immune-associated pathways and 
colitis disease activity index (DAI) at colitis and recovery time points. Spearman correlation r and p 
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Figure 8. at a sc res i icate roa scale c a ges i tr scri t a ance for e es associate
ultiple i une and cancer path ays that are also highly correlated ith the colitis I. ( ) olon
tissue r ssi ath ay Z scores at Pre-DSS, colitis and recovery time points for mice fed
AIN or TWD diets. Scores are shown as Tukey box plots (n = 6 to 8) for selecte i e cancer
pathways. * p < 0.05 and ** p < 0.01 compared to time point-matched AIN control as determined by the
non-parametric Steel-Dwass test. (B) Correlation analyses of immune-associated pathways and colitis
disease activity index (DAI) at colitis and recovery time points. Spearman correlation r and p values
are indicated.
Because the NanoString annotated pathways are broadly descriptive of immune-related functions,
we explored gene ontology enrichment analysis, which provides greater resolution and more specific
insight into biological processes affected by DEGs. Circos plots generated using lists of DEGs for
AIN or TWD at the colitis timepoint also reveal substantial overlap in transcriptional profile for
these two diets, with a large majority of DEGs for the AIN diet also regulated in mice fed TWD
(Figure S11). However, a large fraction of DEGs for mice fed TWD were unique, with relatively
few overlapping GO biological process terms with the AIN diet group (Figure S11). Alternatively,
Nutrients 2020, 12, 544 21 of 35
at the recovery time point, while many more genes were uniquely expressed in TWD-fed mice,
a greater fraction of those unique transcripts were associated with similar GO biological process
terms. For mice fed AIN, notable biological processes that were significantly enriched at colitis in
mice fed the AIN diet included inflammatory response (GO:0006954), cell chemotaxis (GO:0060326),
second messenger-mediated signaling (GO:0019932), vascular endothelial growth factor production
(GO:0010573), and leukocyte migration involved in inflammatory response (GO:0002523), among others
(Figure S11). Enrichment of some of these processes persisted to the recovery time point, although some
new terms were identified as well, such as interferon-gamma production (GO:0032609) and defense
response to bacterium (GO:042742). Biological process terms corresponding to the subset of genes
similarly regulated at colitis in both AIN and TWD-fed mice were consistent, with cell chemotaxis
the top term for TWD-exposed mice at both time points. Although some terms appear unique for
TWD, one should note that the terms shown represent a cluster defined by semantic similarity with
very similar genes (e.g., calcium-mediated signaling (GO:0019722) and second messenger-mediated
signaling (GO:0019932)) (File S6). However, the TWD DEGs were associated with some biological
processes that appeared exclusive to that diet group, such as T cell activation (GO:0042110) and T cell
differentiation involved in immune response (GO:0002292) at the colitis time point or T-helper 17 type
immune response (GO:0072538) and defense response to protozoan (GO:0042832) at the recovery time
point. To gain further insight into processes associated with the transcriptional response unique to
TWD exposure, ontology analyses were also performed using only the set of DEGs that were not also
regulated in AIN-fed mice at both colitis and recovery time points (Figure S12). During colitis, the few
overlapping GO terms are likely connected with second messenger signaling, as suggested by the high
significant enrichment for calcium-mediated signaling (GO:0019722). Genes with non-overlapping
GO terms were associated with processes including T cell activation (GO:004211) and T cell cytokine
production (GO:0002369). At recovery, although substantially more overlap in biological process terms
for the different diet gene sets was evident, the DEGs unique to TWD were associated most strongly
with B cell activation (GO:0042113) and T-helper 17 type immune response (GO:0072538)—terms that
did not appear in any of the AIN ontology results (File S6). These trends were largely confirmed
by STRING-db network mapping, which showed that genes associated with cytokine-mediated cell
signaling, B-cell activation and lymphocyte proliferation, leukocyte migration involved in inflammatory
response, and regulation of granulocyte chemotaxis were most predominantly impacted by exposure
to TWD at the colitis time point (Figure 9A). At recovery, DEGs involved in cytokine-mediated cell
signaling, antigen processing, cellular catabolic processes, and regulation of granulocyte chemotaxis
and regulation of T-helper 2 cell differentiation were identified (Figure 9B). Network maps for colitis
vs. pre-DSS and recovery vs. pre-DSS time points within each diet group are provided in the
supplementary material (Figures S11–S14). Additionally, visualization of DEGs mapped to top
KEGG pathways, including inflammatory bowel disease (mmu05321), cytokine-cytokine receptor
interaction (mmu04060), the NF-Kappa B signaling pathway (mmu04151), and the cell adhesion
pathway (mmu04514) are provided for each diet for colitis vs. pre-DSS or recovery vs. pre-DSS time
point comparisons (Figures S15–S22).
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genes in colon tissues of mice fed TWD as compared to their AIN counterparts at colitis (A) or recovery
(B). Network of DEGs in mice fed TWD Network interactions were modeled using the STRING database
(string-db.org) with a minimum required interaction score ≥0.9, and clusters were identified using
the Markov Cluster (MCL) algorithm with inflation parameter of 1.5. The network was visualized in
Cytoscape. Major groupings include transcripts associated with cellular response to cytokine-mediated
cell signaling and the STAT cascade (blue), antigen processing (yellow), cellular protein catabolic
processes (red), regulation of granulocyte chemotaxis (green and purple).
Comparisons of the impact of AIN and TWD on representative genes over the course of colitis
onset and recovery are depicted in Figure 10. An examination of expression for selected genes
representative of these pathways reveals two patterns of interest. First, responses of these DEGs were
routinely more robust in mice fed TWD than AIN during colitis, as noted for genes associated with
interferon response (Ifna1, Ifnb1, Ifng, Nos2), inflammation (Il1a, Il4, Il6, Il17f, Il12b, TNF, Nlrp3, S100a8),
and chemokines and their receptors (Ccl3, Ccr7, Cxcl10, Cxcr4, Csf3, Csf3r), among others. Second,
many genes differentially expressed between TWD and AIN diets at colitis were still upregulated at the
recovery time point compared to pre-DSS, though not markedly more so in TWD-fed mice (e.g., Ifna1,
Il6, Tnf ). However, a number of transcripts were found to be uniquely over- or under-expressed in
TWD-fed mice at recovery compared to their AIN counterparts, including several DEGs associated with
antigen processing and T-cell function pathways (Cd5, Vcam1, Cd247, Cd74, Btla, H2-Ab1), interferon
(Ifit2, Isg15, Nos2), inflammation (Il1a, Il1b, Il3ra1, Il15, and Nlrp3), and B-cell activation (Cxcr5, Cd22,
Ms4a1, Tnfsf13b). Prolonged activation of these pathways through recovery from DSS-induced colitis
correlated well with observed disease activity (Figure 8B).
Immune cell type profiling in colon mucosa based on the expression of cell-specific transcripts
was performed using NanoString software (Figure 11). Consistent with our prior histopathological
assessment of inflammation in colon tissues of mice provided DSS (Figures 1J and 5), neutrophils
increased in both AIN- and TWD-fed mice during colitis, though significantly more so in mice provided
TWD (Figure 11A). Furthermore, in agreement with our prior observations, this apparent increase in
neutrophil abundance in TWD-fed mice persisted through recovery from DSS-induced inflammation
and gut injury. Similar patterns were evident for other immune cell types, including T-cells, CD8
T-cells, and B-cells, though not apparently for all CD45+ cells. When considered as a fraction of the
total population of infiltrating leukocytes (TILs) in the tissue, B-cells were enriched in TWD-fed mice
at colitis while both B-cells and neutrophils were enriched at recovery (Figure 11B).
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Figure 10. Expression profiles for selected genes of interest associated with immune and 
inflammatory responses. Values shown are the average log2 ratio ± SEM for selected genes calculated 
with AIN/Pre-DSS as the reference. Significant differences in expression (FDR-corrected q-value < 0.05 
and log2 ratio > 1 or < -1) between TWD and AIN diets at each time point are noted as follows: * q < 
0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Statistical results for comparisons across time points 
within each diet group are not shown here, but are available in File S2 along with the specific FDR q-










































































































































































































































































































































































Figure 10. Expression profiles for selected genes of interest associated with immune and inflammatory
responses. Values shown are the average log2 ratio ± SEM for selected genes calculated with
AIN/Pre-DSS as the reference. Significant differences in expression (FDR-corrected q-value < 0.05 and
log2 ratio > 1 or < −1) between TWD and AIN diets at each time point are noted as follows: * q < 0.05;
** p < 0.01; *** p < 0.001; **** p < 0.0001. Statistical results for comparisons across time points within
each diet group are not shown here, but are available in File S2 along with the specific FDR q-values for
the significant observations noted in the figure. Pre, pre-DSS; Col, colitis; Rec; recovery.
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Figure 11. Profiling of immune cell types in colon tissues obtained at pre-DSS, colitis or recovery time 
points from mice fed either AIN or TWD. (A) Data shown are the log2 scores for the indicated cell 
types, and only those cell types that met quality control testing for correlation of marker gene 
expression (p < 0.05) are shown. Scores may be compared within a cell type for both diet and time 
point, but comparisons across cell types are not appropriate for this method of quantitation. Scores 
do not convey information about the absolute number of cells in the samples. (B) Data shown are the 
relative cell type measurements with respect to total infiltrating leukocytes (TILs). * p < 0.05 and ** p 
< 0.01 compared to time point-matched AIN control as determined by the non-parametric Steel-
Dwass test. 
As we reported previously, mice consuming the DIO diet acquired an obesity/metabolic 
syndrome phenotype whereas consumption of the TWD did not significantly alter any biomarkers of 
metabolic health [36], a somewhat surprising observation considering that the TWD diet contains 
substantially more fat than the AIN93G diet (35% compared to 17% of total kcal, respectively). Thus, 
the colon tumor-promoting effect of the TWD was unrelated to a metabolic syndrome phenotype or 
systemic inflammation induced by consumption of a high fat diet. Furthermore, our observations 
also showed that the high fat DIO diet did not enhance colon cancer in the AOM + DSS mouse model, 
a finding somewhat contrary to prior observations for development of preneoplastic lesions in rats 
[37,38]. The results of these comparisons of the high fat DIO diet to the TWD point to the critical need 
to employ a diet model that more broadly represents typical human nutrition. Had the first 


















































































































Figure 11. Profiling of i une cell types in colon tissues obtained at pre-DSS, colitis or recovery
time points fro mice fed either AIN or TWD. (A) Data shown are the log2 scores for the indicated
cell types, and only those cell types that et quality control testing for correlation of marker gene
expression (p < 0.05) are shown. Scores may be compared within a cell type for both diet and time point,
but comparisons across cell types are not appropriate for this method of quantitation. Scores do not
convey information about the absolute number of cells in the samples. (B) Data shown are the relative
cell type measurements with respect to total infiltrating leukocytes (TILs). * p < 0.05 and ** p < 0.01
compared to time point-matched AIN control as determined by the non-parametric Steel-Dwass test.
4. Discussion
Herein, w report that a rodent diet that recapitulates U.S. nutrition patter s with respect to
macro- and micronutrient content markedly enhanced colon tumorige esis in multiple mouse models
of CAC as compared to basal diet optimized f r rodent health. This study is the second from our
group to show that the TWD functions to promote colon cancer in mice. Previously, w showed that
A/J mice i itiated with AOM and fed TWD for 16 weeks developed significantl more aberra t crypt
foci and total crypt cells than mice fed the AIN93G diet [24]. Now, we report that c nsumption of TWD
significantly en nced tumorigenesis n C57BL/6J mice using both th AOM + DSS and ApcMin/+ + DSS
models of CAC, ereas small intest nal tumorige esis was not affected. Furth rmore, thi increased
tumor response wa attributed to the micr nutrient fr ction of the TWD, and restoration of calcium
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and vitamin D to standard amounts ameliorated the tumor-promoting effects of the TWD. Exposure
to the TWD markedly enhanced DSS-induced symptoms of colitis, exacerbated inflammation and
mucosal injury pathologies in colon tissues, and delayed tissue repair after cessation of DSS exposure.
This study is the first to assess the dynamics of immune and cancer pathway gene expression during
the onset and resolution of DSS-induced colitis and the first to employ highly multiplexed, direct
digital detection NanoString technology for analysis of a colitis transcriptome in mouse colon mucosa.
Results of these targeted gene expression analyses point to striking up-regulation of hundreds of
genes associated with interferon response, inflammation, innate immunity, adaptive immunity, and
chemokines and receptor pathways in mice fed TWD as compared to the standard AIN diet during
active colitis. In a pattern that mirrored the persistent elevation in inflammation and mucosal injury
observed in the AOM + DSS longitudinal study, dysregulation of many of these genes persisted through
recovery from gut injury, in addition to the stimulation of other pathways, such as B-cell activation
and antigen processing. Collectively, these data suggest that enhanced and sustained inflammation
and dysplasia of the colon mucosa is a probable mechanism for promotion of CAC by the TWD.
As we reported previously, mice consuming the DIO diet acquired an obesity/metabolic syndrome
phenotype whereas consumption of the TWD did not significantly alter any biomarkers of metabolic
health [36], a somewhat surprising observation considering that the TWD diet contains substantially
more fat than the AIN93G diet (35% compared to 17% of total kcal, respectively). Thus, the colon
tumor-promoting effect of the TWD was unrelated to a metabolic syndrome phenotype or systemic
inflammation induced by consumption of a high fat diet. Furthermore, our observations also showed
that the high fat DIO diet did not enhance colon cancer in the AOM + DSS mouse model, a finding
somewhat contrary to prior observations for development of preneoplastic lesions in rats [37,38].
The results of these comparisons of the high fat DIO diet to the TWD point to the critical need to employ
a diet model that more broadly represents typical human nutrition. Had the first experiment design
included only the DIO diet as the model Western diet, we could have easily (and erroneously) concluded
that colorectal cancer risk in C57BL/6J mice was unaffected by the Western nutrition pattern. Moreover,
we would have missed the noteworthy discovery that inappropriate micronutrient consumption
strongly increased colon tumorigenesis in this mouse model, as evidenced by highly similar results
for the TWD and the VMM diets, both of which had vitamin and mineral content that reflects typical
American nutrition on an energy density basis. Modification of macronutrient content alone (i.e., DIO
and MM diets) did not increase colorectal tumorigenesis, an observation that also points to a critical
role for micronutrients in promoting colorectal carcinogenesis in this pre-clinical mouse model.
The nutrient density approach was previously employed by Newmark et al. [18] to construct
a Western-type diet containing the amounts of fat, phosphorous, calcium, and vitamin D observed
in typical American diets. Newmark’s Western diet promoted spontaneous hyper-proliferation and
hyperplasia in colonic epithelium of aged C57BL/6J mice. In a subsequent study, this group further
modified this experimental diet by reducing amounts of nutrient components critical for methyl donor
generation, including folic acid, methionine, and vitamin B12 [20]. Consumption of this modified
western diet led to higher rates of spontaneous colon adenoma and carcinoma development in normal
mouse colon. In formulating the TWD, we expanded upon this nutrient density approach for diet
formulation to include the complete array of macro- and micronutrients included in commercial
semi-purified rodent diets [23]. On an energy density basis, amounts of vitamins B6, B12, and folate in
the TWD are about 33% to 50% lower as compared to the AIN93G control diet, while calcium and
vitamin D levels are approximately 60% lower. In experiment B, we sought to determine if certain
micronutrients could be added back to the TWD to block the tumor-promoting phenotype, following
an approach somewhat like that of Newmark’s group [18]. We hypothesized that TWD-enhanced
tumorigenesis could be abrogated by adding back to the TWD the original amounts of calcium
and vitamin D or dietary methyl donors (B2, B6, B12, folate and choline) to match the AIN93G diet.
The addition of calcium and vitamin D to the TWD decreased colitis disease activity, tumor multiplicity
and burden compared to mice fed the unmodified TWD. The addition of methyl donor micronutrients
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to the TWD resulted in a modest reduction in colitis and tumorigenesis, but there were no significant
differences in any of the study endpoints between mice fed the methyl donor-supplemented TWD
and the unmodified TWD (Figure 2A–C). Because the TWD models the typical U.S. diet with respect
to nearly all major micro- and macronutrient components, it is not possible to conclude that these
several micronutrients we investigated here are exclusively responsible for the tumor-enhancing effect
of TWD. Nevertheless, our strategy is an important advance on prior studies that investigated the
impact of only one or a select few components of the Western diet on colon cancer.
As noted above, evidence from human epidemiological studies and experiments in animal models
points to a role for calcium and vitamin D in modulation of CRC [39–41]. A review of epidemiological
evidence suggests that dietary intake of not more than 1000 mg/day calcium and 1000 to 2000 IU/day
vitamin D may be protective against CRC [42]. In 2006, Wactawski-Wende reported that results
from the Women’s Health Initiative, the largest randomized controlled clinical intervention to date,
suggested that combined intake of 1000 mg/day calcium and 400 IU/day vitamin D3 over seven years
did not reduce CRC incidence [43]. However, reanalysis of these data accounting for the personal use
of supplements revealed that the calcium and vitamin D intervention indeed improved total cancer
outcome, including CRC incidence [44].
Calcium functions to regulate cellular signaling, cell proliferation and cell growth, while vitamin
D is critical for adequate uptake of calcium in the small intestine. A 24-week study using Apc1638N/+
mice, which have a truncation on codon 1638 of the tumor suppressor Apc gene, found that feeding a
modified AIN76A diet with half the content of vitamin D and 90% less calcium resulted in the formation
of colonic adenomas and carcinomas and enhanced expression of cyclin D1 and anti-apoptotic protein
Bcl-2, which are commonly overexpressed in colorectal cancer [45]. In a different study using this same
diet fed to C57BL/6J mice for 3 or 6 months, researchers identified important transcriptome changes
associated with induction of the oxidative stress response pathway [46]. Moreover, calcium and vitamin
D were determined to be important regulators of bile acid synthesis and excretion. Vitamin D has been
shown to be involved in the detoxification of bile acids through the regulation of fibroblast growth
factor 15 [47] and the vitamin D receptor [48] in the intestine, while calcium has been shown to increase
fecal fatty acid excretion [49,50]. Bile acids contribute to colorectal carcinogenesis by increasing cellular
oxidative stress, and they have been associated with the promotion of cell populations resistant to their
apoptotic effects [51]. Bile acids are the main end products of cholesterol catabolism in mammals, and,
hence, they are generally found in high levels in individuals that consume a high-fat diet [52]. Thus,
the combined impact of excess fat with low calcium and vitamin D content in the TWD could explain
the promoting effect of this diet on colon tumorigenesis observed in this study.
Numerous studies have linked vitamin D deficiency with increased risk of IBD, a major risk
factor for development of CRC [53–57], although it is unclear whether this deficiency is a cause of
IBD or a consequence. However, there is ample evidence supporting a role for the bioactive form of
vitamin D, 1,25-dihydroxycholecalciferol (D3), as a potent immune and inflammation modulator in the
gastrointestinal tract. D3 has been shown to have an important role in maintaining gut homeostasis by
reducing inflammation, including reduction in the activation of Th1 and Th17 cells and suppressing
activation of pro-inflammatory cytokines IL-1, IL-6, IL-8, and TNF [reviewed in 57–59]. Vitamin D
deficiency shifts this system toward a pro-inflammatory state that favors Th1 and Th17 activation and
increased expression of TNF, IFNγ, and IL-17, as well as elevated expression of pro-inflammatory Il-4,
IL-5 and IL-13, and gut barrier dysfunction. In this study, the pattern of gene expression in TWD-fed
mice (vitamin D depleted to just 40% of the AIN diet), generally fits well with this pro-inflammatory
model of vitamin D deficiency. During colitis, TWD increased expression of Tnf by 2.5-fold, Il1b by
2.8-fold, Il4 by 4.8-fold, Il6 by 3.3-fold, Ifng by 3.8, and Il17f by 4.2-fold as compared to mice fed the
AIN diet. Furthermore, gene ontology analyses revealed activation of the T-helper 17 type immune
response during recovery from DSS-triggered gut injury in mice fed TWD, but not those provided
AIN. Although mucosa samples for experiment B were not available for gene expression analyses, we
can surmise that the restoration of vitamin D (along with calcium) in this experiment likely reversed
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the pro-inflammatory effects of the vitamin D deficient TWD diet on mucosal gene expression and
allowed for a shift towards gut homeostasis, as suggested by the observed decrease in symptoms of
colitis following DSS treatment.
Choline, folate, and vitamins B6 and B12 are essential in cellular biosynthetic pathways due to their
roles as donors of methyl groups for one carbon-metabolism [58], and consequently influence DNA
methylation, cycling of s-adenosylmethionine, activity of DNA methyltransferases and miRNAs with
both oncogenic and tumor suppressive functions [59]. These methyl donor micronutrients are present
in the AIN93G diet at substantially greater levels than the RDA value for humans, when compared
on an energy density basis [23]. Moreover, the TWD contains substantially lower levels of these
micronutrients than are present in the AIN93G diet. A case-control study of subjects from the
Multiethnic Cohort study found that people in the highest quartile for pyridoxal-5′-phosphate intake
(active form of B6) had a 48% reduction in CRC risk [60]. A meta-analysis that included 7 cohort-studies
and 9 case-control studies found a 25% lower risk of CRC among those in the highest category of dietary
folate intake compared with those in the lowest category, while only a 5% lower risk was observed for
total folate intake (including supplements) [61]. An animal study using male Sprague-Dawley rats fed
with either a diet with 50 µg/kg diet of vitamin B12 or a diet with no vitamin B12 found that, after 10
weeks of feeding, rats fed the deficient diet displayed a 35% decrease in genomic methylation and a
105% increase in base substitution of uracil. Although some studies have found weak or no association
between CRC risk or development and dietary B-vitamins [62–64], the supporting evidence points to a
complex interaction between other nutrients in the diet. Furthermore, the low levels of B-vitamins in
the TWD could explain the promoting effect on tumorigenesis observed in animals fed this diet.
To determine whether increased CRC associated with the TWD was specific to the AOM + DSS
model, we fed ApcMin/+ either AIN, DIO, or the TWD. ApcMin/+ mice are a genetic model of CRC that
develop intestinal tumors spontaneously without administration of AOM. Similar to our previous
investigations, the TWD increased colon tumor multiplicity and burden relative to both mice fed either
the AIN or DIO diets. However, there were no differences between diet groups for small intestinal
tumorigenesis. These results confirm our earlier findings and suggest CRC phenotype associated with
the TWD is not due to interactions between dietary factors and metabolism of the AOM carcinogen.
The histological assessment of colon tissues revealed that consumption of the TWD enhanced
inflammation over the progression of colitis, through recovery to tumorigenesis. Thus, we sought
to gain insights into the underlying mechanisms for TWD-enhanced tumorigenesis via targeted
multiplex gene expression analysis using the nCounter transcript counting platform. For mice fed
the standard AIN diet, results of these analyses confirmed that DSS-induced colitis was associated
with broad changes in expression of genes associated with adaptive, innate, inflammation, interferon,
and chemokines and receptors pathways, with many of these responses persisting, albeit to a lesser
extent, through the recovery phase 14 days after cessation of DSS treatment. Remarkably, exposure to
the TWD exacerbated these responses across the board such that many more DEGs were identified at
colitis and recovery stages with markedly greater changes in expression as compared to the pre-DSS
controls. When considering the overall profile of gene expression, segregation of the diet groups
was evident, even prior to the induction of colitis by DSS. The apparent distinct gene expression
profiles following three weeks of feeding TWD were likely caused by the upregulation of several genes
involved in interferon response (Ifit2, Ifit3, and Nlrc5), as well as other more modest, but not significant,
changes in genes associated with complement, leukocyte function and MHC pathways suggested by
global significance scores. Exposure to the TWD may prime colon tissue toward a more responsive
state such that the immune and inflammation responses upon challenge with DSS were exacerbated
compared to mice fed the standard AIN diet. Furthermore, very distinct transcriptional responses
were evident during recovery from DSS-induced gut injury, most obviously revealed by principal
components analysis, which supports prior histological observations that TWD exposure impeded
the repair of colon mucosa and reduction in inflammation. Moreover, cell type profiling suggested
that colon mucosa of TWD-exposed mice was typified by an increase in total infiltrating leukocytes,
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including elevated neutrophils, T-cells, dendritic cells, and B-cells, with an apparent enrichment in the
relative abundance of B-cells during colitis and recovery. Interestingly, Bergomas, et al. [65] reported
that chronic inflammation induced in the AOM + DSS mouse model of CAC was associated with
an increase in amount of lymphoid tissue in the colon mucosa and the development of intratumor
tertiary lymphoid structures with highly compartmentalized B-cells, T-cells, mature dendritic cells and
a network of CD21+ follicular dendritic cells.
Given that the PanCancer Immune Profiling probe set captures expression data for up to 750
genes, we sought to compare the transcriptional profiles for our TWD-exposed mice during colitis to
other available datasets in animal models and human UC patients. Our comparison focused primarily
on those studies using genome-wide methodologies including a genome-wide microarray study of
mouse colon mucosa collected after 6 days exposure to 3% DSS [66], RNAseq analysis of colon mucosa
collected after exposure to 4% DSS (5 days treatment, with collection on day 8) [67], RNAseq analysis
of colon mucosa from the PAC-Il10-/- mouse model compared to wildtype [67], a microarray study
of colon tissue samples from human UC patients compared to healthy controls [68], and an RNAseq
assessment of colon tissues from human UC patients versus healthy controls [67]. (We note that other
reports also employed genome-wide analyses to examine the colon transcriptome in DSS or IL-deficient
mice, although the complete results or underlying data were not publicly available for us to use in this
comparative analysis). When comparing the transcript profiles across these various studies, a list of 19
commonly regulated genes were identified including C3, Ccl2, Ccl3, Ccl4, Ccr2, Cxcl1, Cxcl10, Cxcl2,
Cxcl5, Cxcl9, Icam1, Il1b, Lcn2, Mmp9, Nos2, S100a8, Stat1, Tnf, Vcam1 (Table S1).
Because the mouse DSS colitis model most closely approximates human UC, we compared the
transcript profile obtained in this study using the NanoString platform to the list of DEGs identified by
Fang, et al. [66] using the 3% DSS model and to DEGs identified by Wu, et al. [68] in human UC patients
(Figure 12). A larger set of commonly regulated genes was discovered (46 total), with notable consistent
expression for many transcripts across all studies, including Csf3r, Cxcl2, Cxcl5, Ido1, Il1b, Lcn2, Mmp9,
S100a8, and Spp1 (Figure 11B,C). Alternatively, a large portion of the colitis TWD-regulated gene set
was unique to this study, as these genes did not meet significance criteria in either the mouse DSS
or human UC genome-wide studies (Figure 12B,D). Interestingly, these unique DEGs are annotated
with GO biological process terms associated with IFNγ regulation and secretion (GO:0032609), IL-13
secretion (GO:0030101), and immune response to tumor cell (GO:0002418) (Figure 12D). However,
we did note very high overlap in biological processes for all the DEGs identified at colitis in TWD-fed
mice (note blue lines in Figure 12B), suggesting functional redundancy captured by other DEGs in the
comparison studies. The differences in DEGs identified in our study compared to others using DSS
to induce colitis may be related to the amount and duration of DSS treatment (1% for 10 days in this
study versus 3% to 4% for 5 to 8 days in other reports). Or, the differences may be due to the nature of
the NanoString technology, which allows for detection of small populations of mRNA, lacks bias that
can be introduced through sample processing and amplification, and has the capacity for detecting
transcripts in less-than-ideal quality samples.
This work has some limitations. First, our animal studies focused on the DSS-induced model of
colitis-associated colorectal cancer, and we have not yet explored the impact of TWD in the Il10-/- mouse
model of spontaneous colonic inflammation. Results of the comparative transcriptomics analyses
across DSS and IL-10 deficient mouse models, however, suggest that our TWD-enhanced DSS colitis
model shares some similar transcriptional responses as observed in Il10-/- mice. Furthermore, we have
investigated the effects of TWD in two mouse strains to date (C57BL/6J in this study and A/J males
in [24]). However, given the influence of genetic background on susceptibility to inflammation and the
progression of disease [69,70], a more extensive evaluation of strain-dependent responses to the TWD
in context of gut inflammation would be valuable for future work. Our transcriptomics approach
leveraged a reasonable sample size and a limited gene target set for a relatively high-powered analysis
of mucosal gene expression in this pre-clinical animal model of CAC. The NanoString PanCancer
Immune Profiling probe set was selected based on the hypothesis, supported by histopathological
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evidence, that TWD exposure enhanced colonic inflammation. On the other hand, this targeted
transcriptomics approach limited our possible observations to genes related to immune response or
inflammation processes. There remains the possibility that other unrelated pathways were affected
by exposure to the TWD during colitis or recovery from gut injury. Last, the experiments included
herein did not include an assessment of the microbiome composition nor manipulations of the gut
microbiome (e.g., antibiotic exposure) to determine the contribution of gut bacteria to TWD-driven
changes in gut inflammation. While of high interest to our group, these additional experimental factors
and analyses were beyond the scope of the present work.Nutrients 2020, 12, x FOR PEER REVIEW 30 of 35 
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5. Conclusions
Taken together, our observations indicate that consumption of the TWD markedly enhanced
colitis, delayed recovery from gut injury, and promoted colon tumorigenesis. Furthermore, these effects
were associated with extensive changes in expression of immune-related genes in the colon mucosa.
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The use of a basal diet that more completely modeled Western nutrition on an energy density basis
revealed that the micronutrient fraction of the diet—primarily vitamin D and calcium, and, to a lesser
extent, methyl donor micronutrients—was the driving force in promoting gut inflammation. Evidence
from this work supports the idea that a rodent diet more representative of the diet consumed by the
majority of Americans is necessary to appropriately evaluate colon cancer risk and to develop specific
and effective prevention strategies [71]. Results of studies using the TWD may result in pre-clinical
findings that can be more accurately translated to at-risk populations. Moreover, future work by our
team will focus on the contribution of the TWD to the composition of the gut microbiome in context
of colitis onset, recovery from gut injury, and subsequent tumorigenesis, as well as the potential
benefit of various dietary interventions with functional foods to modulate the gut microbiome and
suppress Western-diet enhanced CAC. Furthermore, given the profound impact of the TWD on colon
carcinogenesis and the mounting evidence for perinatal or transgenerational impacts of diet on cancer
risk, we are also investigating the impact of TWD provided via the maternal diet on risk of cancer
to offspring.
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